当前位置: 首页 > 期刊 > 《医药产业资讯》 > 2011年第34期 > 正文
编号:12144626
食管癌放疗前后外周血癌胚抗原mRNA与蛋白检测的对比研究(3)
http://www.100md.com 2011年12月5日 薛金俊 袁昕 殷旭东 汪瑞 张正荣 夏广鑫
第1页

    参见附件(2523KB,3页)。

     [5] Eisenhauer EA, Therasse P, Bogaerts J, et al. New response evaluation criteria in solid tumors: revised RECIST guideline (version 1.1) [J]. Eur J Cancer,2009,45(2):228-247.

    [6] Huang P, Wang J, Guo Y, et al. Molecular detection of disseminated tumor cells in the peripheral blood in patients with gastrointestinal cancer [J]. J Cancer Res Clin Oncol,2003,129(3):192-198.

    [7] 任群,余建和,吴祥.FP方案同步放射治疗食管癌的临床分析[J].实用临床医药杂志,2010,14(13):119-120.

    [8] Ring AE, Zabaglo L, Ormerod MG, et al. Detection of circulating epithelial cells in the blood of patients with breast cancer: Comparison of three techniques [J]. Br J Cancer,2005,92(5):906-912.

    [9] Qiu MZ, Li ZH, Zhou ZW, et al. Detection of carcinoembryonic antigen messenger RNA in blood using quantitative real-time reverse transcriptase-polymerase chain reaction to predict recurrence of gastric adenocarcinoma [J]. J Transl Med,2010,8:107.

    [10] Ishigami S, Sakamoto A, Uenosono Y, et al. Carcinoembryonic antigen messenger RNA expression in blood can predict relapse in gastric cancer [J]. J Surg Res,2008,148(2):205-209.

    [11] Nakashima S, Natsugoe S, Matsumoto M, et al. Clinical significance of circulating tumor cells in blood by molecular detection and tumor markers in esophageal cancer [J]. Surgery,2003,133(2):162-169.

    [12] Liu Z, Jiang M, Zhao J, et al. Circulating tumor cells in perioperative esophageal cancer patients: quantitative assay system and potential clinical utility [J]. Clin Cancer Res,2007,13(10):2992-2997.

    [13] Tanaka K, Yano M, Motoori M, et al. CEA-antigen and SCC-antigen mRNA expression in peripheral blood predict hematogenous recurrence after resection in patients with esophageal cancer [J]. Ann Surg Oncol, 2010,17(10):2779-2786.

    (收稿日期:2011-07-26)

您现在查看是摘要介绍页,详见PDF附件(2523KB,3页)